Alpha Centric Advisors LLC Aerie Pharmaceuticals Inc Transaction History

Alpha Centric Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	SELL	$6.37 - $15.23 $872,690 - $2.09 Million	-137,000 Closed	0 $0
Q4 2021 Feb 25, 2022	BUY	$7.02 - $13.33 $628,290 - $1.19 Million	89,500 Added 188.42%	137,000 $962,000
Q3 2021 Mar 09, 2022	BUY	$11.32 - $16.63 $537,700 - $789,925	47,500 New	47,500 $542,000
Q1 2021 Mar 09, 2022	SELL	$13.12 - $20.9 $52,480 - $83,600	-4,000 Closed	0 $0
Q4 2020 Mar 11, 2022	BUY	$9.12 - $14.49 $35,568 - $56,511	3,900 Added 3900.0%	4,000 $54,000

Q3 2020 Mar 11, 2022	BUY	$10.46 - $14.46 $1,046 - $1,446	100 New	100 $1,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Centric Advisors LLC with notifications on news.